1190891-71-4 Usage
General Description
2-(4-methyl-3-nitrophenyl)pyrimidine is a chemical compound with a molecular formula C11H9N3O2. It is a pyrimidine derivative with a nitrophenyl group attached to the 2-position of the pyrimidine ring and a methyl group at the 4-position. 2-(4-methyl-3-nitrophenyl)pyrimidine has potential applications in medicinal chemistry and pharmaceutical research due to its structural properties and potential biological activity. It may be used as a building block in the synthesis of novel pharmaceutical compounds or as a reference standard for analytical testing. Additionally, the presence of the nitro and methyl groups in its structure suggests potential reactivity and interactions with biological targets, making it a valuable compound for further investigation in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 1190891-71-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,0,8,9 and 1 respectively; the second part has 2 digits, 7 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1190891-71:
(9*1)+(8*1)+(7*9)+(6*0)+(5*8)+(4*9)+(3*1)+(2*7)+(1*1)=174
174 % 10 = 4
So 1190891-71-4 is a valid CAS Registry Number.
1190891-71-4Relevant academic research and scientific papers
Meta-Selective CAr-H Nitration of Arenes through a Ru3(CO)12-Catalyzed Ortho-Metalation Strategy
Fan, Zhoulong,Ni, Jiabin,Zhang, Ao
supporting information, p. 8470 - 8475 (2016/07/26)
The first example of transition metal-catalyzed meta-selective CAr-H nitration of arenes is described. With the use of Ru3(CO)12 as the catalyst and Cu(NO3)2·3H2O as the nitro source, a wide spectrum of arenes bearing diversified N-heterocycles or oximido as the directing groups were nitrated with meta-selectivity exclusively. Mechanism studies have demonstrated the formation of a new 18e-octahedral ruthenium species as a key ortho-CAr-H metalated intermediate, which may be responsible for the subsequent meta-selective electrophilic aromatic substitution (SEAr). Moreover, this approach provides a fast-track strategy for atom/step economical synthesis of many useful pharmaceutical molecules.
THERAPEUTIC AGENT FOR CEREBRAL INFARCTION
-
, (2012/08/08)
The invention provides a therapeutic drug for ischemic stroke. The therapeutic drug has the formula (I) wherein each symbol is as defined herein, or a pharmacologically acceptable salt thereof, or a solvate thereof, as an active ingredient.
